Movement disorders in catatonia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 8, 2015, Pages 825-832

  Wijemanne, Subhashie ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; LORAZEPAM; NEUROLEPTIC AGENT; ZOLPIDEM; BENZODIAZEPINE DERIVATIVE;

BUSH FRANCIS CATATONIA RATING SCALE; CATATONIA; CLINICAL FEATURE; DEFENSE MECHANISM; DIAGNOSTIC TEST; DSM-IV; ELECTROCONVULSIVE THERAPY; GESTURE; HUMAN; MOTOR DYSFUNCTION; MUTISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; REVIEW; RIGIDITY; STEREOTYPY; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; COMPLICATION; MOVEMENT DISORDERS;

BENZODIAZEPINES; CATATONIA; ELECTROCONVULSIVE THERAPY; HUMANS; MOVEMENT DISORDERS;

EID: 84940666656     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309098     Document Type: Review

References (80)

1. Kahlbaum KL. Catatonia. Translated by Levi Y, Pridon T. Johns Hopkins University Press, 1973.
2. Francis A. Catatonia: diagnosis, classification, and treatment. Curr Psychiatry Rep 2010;12:180-5.
3. Pfuhlmann B, Stober G. The different conceptions of catatonia: historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci 2001;251(Suppl 1):I4-7.
4. van der Heijden FM, Tuinier S, Arts NJ, et al. Catatonia: disappeared or under-diagnosed? Psychopathology 2005;38:3-8.
5. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 2010;36:314-20.
6. Daniels J. Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci 2009;21:371-80.
7. Francis A, Fink M, Appiani F, et al. Catatonia in diagnostic and statistical manual of mental disorders, fifth edition. J ECT 2010;26:246-7.
8. Rosebush PI, Hildebrand AM, Furlong BG, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-62.
9. Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med 2005;35:1667-75.
10. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003;160:1233-41.
11. Smith JH, Smith VD, Philbrick KL, et al. Catatonic disorder due to a general medical or psychiatric condition. J Neuropsychiatry Clin Neurosci 2012;24: 198-207.
12. Bush G, Fink M, Petrides G, et al. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-43.
13. Jaimes-Albornoz W, Serra-Mestres J. Catatonia in the emergency department. Emerg Med J 2012;29:863-7.
14. Saddawi-Konefka D, Berg SM, Nejad SH, et al. Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. A case series and review of the literature∗. Crit Care Med 2014;42:e234-41.
15. Fink MT, Taylor MA. Catatonia. A clinician's guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press, 2003.
16. Tuerlings JH, van Waarde JA, Verwey B. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment. Gen Hosp Psychiatry 2010;32:631-5.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-V. Washington DC: American Psychiatric Association, 2013.
18. Sienaert P, Rooseleer J, De Fruyt J. Measuring catatonia: a systematic review of rating scales. J Affect Disord 2011;135:1-9.
19. Bush G, Fink M, Petrides G, et al. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-36.
20. Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res 1997;27:83-92.
21. Azzam PN, Gopalan P. Prototypes of catatonia: diagnostic and therapeutic challenges in the general hospital. Psychosomatics 2013;54:88-93.
22. Morris JC, Jankovic J. Neurological clinical examination. London, UK: Hodder Arnold, 2012:1-128.
23. Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci 2001;251(Suppl 1):I8-13.
24. Dhossche DM, Stoppelbein L, Rout UK. Etiopathogenesis of catatonia: generalizations and working hypotheses. J ECT 2010;26:253-8.
25. Fink M, Taylor MA. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1182-3; author reply 1184-1185.
26. Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand Suppl 2013;(441):1-47.
27. Hervey WM, Stewart JT, Catalano G. Diagnosis and management of periodic catatonia. J Psychiatry Neurosci 2013;38:E7-8.
28. Stober G, Saar K, Ruschendorf F, et al. Splitting schizophrenia: periodic catatonia-susceptibility locus on chromosome 15q15. Am J Hum Genet 2000;67: 1201-7.
29. Peralta V, Campos MS, de Jalon EG, et al. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr Res 2010;118:168-75.
30. Ungvari GS, Caroff SN, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull 2010;36:231-8.
31. Ungvari GS, Chiu HF, Chow LY, et al. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl) 1999;142:393-8.
32. Peglow S, Prem V, McDaniel W. Treatment of catatonia with zolpidem. J Neuropsychiatry Clin Neurosci 2013;25:E13.
33. Cottencin O, Warembourg F, de Chouly de Lenclave MB, et al. Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1170-6.
34. Northoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry 1999;67:445-50.
35. de Lucena DF, Pinto JP, Hallak JE, et al. Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder. J Clin Psychopharmacol 2012;32:569-72.
36. Carroll BT, Goforth HW, Thomas C, et al. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007;19:406-12.
37. Stober G, Seelow D, Ruschendorf F, et al. Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Hum Genet 2002;111:323-30.
38. Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol 2010;43:307-15.
39. Fink M, Taylor MA, Ghaziuddin N. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neurobiol 2006;72:233-44.
40. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry 2000;176:357-62.
41. Ohta M, Kano Y, Nagai Y. Catatonia in individuals with autism spectrum disorders in adolescence and early adulthood: a long-term prospective study. Int Rev Neurobiol 2006;72:41-54.
42. Dhossche DM, Reti IM, Wachtel LE. Catatonia and autism: a historical review, with implications for electroconvulsive therapy. J ECT 2009;25:19-22.
43. Dejong H, Bunton P, Hare DJ. A systematic review of Interventions used to treat catatonic symptoms in people with autistic spectrum disorders. J Autism Dev Disord 2014;44:2127-36.
44. Billstedt E, Gillberg IC, Gillberg C. Autism after adolescence: population-based 13-to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord 2005;35:351-60.
45. Dhossche D, Fink M, Shorter E, et al. Anti-NMDA receptor encephalitis versus pediatric catatonia. Am J Psychiatry 2011;168:749-50; author reply 750.
46. Titulaer MJ, McCracken L, Gabilondo I, et al. Late-onset anti-NMDA receptor encephalitis. Neurology 2013;81:1058-63.
47. Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges. Ther Clin Risk Manag 2014;10:517-25.
48. Baizabal-Carvallo JF, Stocco A, Muscal E, et al. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 2013;28:543-7.
49. Kruse JL, Jeffrey JK, Davis MC, et al. Anti-N-methyl-d-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management. Ann Clin Psychiatry 2014;26:E1-9.
50. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord 2012;27:935-46.
51. Ungvari GS, Leung CM, Wong MK, et al. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994;89:285-8.
52. Lin CC, Huang TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry 2013;54:1210-14.
53. Gibson RC, Walcott G. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses. Cochrane Database Syst Rev 2008;(4): CD006570.
54. Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull 2010;36:239-42.
55. Tibrewal P, Narayanaswamy J, Zutshi A, et al. Response rate of lorazepam in catatonia: a developing country's perspective. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1520-2.
56. Thomas P, Rascle C, Mastain B, et al. Test for catatonia with zolpidem. Lancet 1997;349:702.
57. Obregon DF, Velasco RM, Wuerz TP, et al. Memantine and catatonia: a case report and literature review. J Psychiatr Pract 2011;17:292-9.
58. Van Den Eede F, Van Hecke J, Van Dalfsen A, et al. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005;20:422-9.
59. Hesslinger B, Walden J, Normann C. Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry 2001;34:25-6.
60. Zisselman MH, Jaffe RL. ECT in the treatment of a patient with catatonia: consent and complications. Am J Psychiatry 2010;167:127-32.
61. van Waarde JA, Tuerlings JH, Verwey B, et al. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. JECT 2010;26:248-52.
62. Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry 2009;66:1173-7.
63. Raveendranathan D, Narayanaswamy JC, Reddi SV. Response rate of catatonia to electroconvulsive therapy and its clinical correlates. Eur Arch Psychiatry Clin Neurosci 2012;262:425-30.
64. Saba G, Rocamora JF, Kalalou K, et al. Catatonia and transcranial magnetic stimulation. Am J Psychiatry 2002;159:1794.
65. Huang YC, Lin CC, Hung YY, et al. Rapid relief of catatonia in mood disorder by lorazepam and diazepam. Biomed J 2013;36:35-9.
66. Grenier E, Ryan M, Ko E, et al. Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report. J Nerv Ment Dis 2011;199:987-8.
67. Prakash O, Bagepally BS. Catatonia and mania in patient with AIDS: treatment with lorazepam and risperidone. Gen Hosp Psychiatry 2012;34:321 e325-6.
68. Hervey WM, Stewart JT, Catalano G. Treatment of catatonia with amantadine. Clin Neuropharmacol 2012;35:86-7.
69. Ene-Stroescu V, Nguyen T, Waiblinger BE. Successful treatment of catatonia in a young man with schizophrenia and progressive diffuse cerebral atrophy. J Neuropsychiatry Clin Neurosci 2014;26:E21-2.
70. McDaniel WW, Spiegel DR, Sahota AK. Topiramate effect in catatonia: a case series. J Neuropsychiatry Clin Neurosci 2006;18:234-8.
71. Nicolato R, Romano-Silva MA, Correa H, et al. Stuporous catatonia in an elderly bipolar patient: response to olanzapine. Aust N Z J Psychiatry 2006;40:498.
72. Chang CH, Hsiao YL, Hsu CY, et al. Treatment of catatonia with olanzapine: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1559-60.
73. Spiegel DR, Varnell C, Jr. A case of catatonia due to posterior reversible encephalopathy syndrome treated successfully with antihypertensives and adjunctive olanzapine. Gen Hosp Psychiatry 2011;33:302 e303-305.
74. Chattopadhyay S, Saha I, Dan A, et al. Clozapine responsive catatonia: A series of five cases. Ind Psychiatry J 2012;21:66-8.
75. Ueda S, Takeuchi J, Okubo Y. Successful use of olanzapine for catatonia following delirium. Psychiatry Clin Neurosci 2012;66:465.
76. Babington PW, Spiegel DR. Treatment of catatonia with olanzapine and amantadine. Psychosomatics 2007;48:534-6.
77. Yoshimura B, Hirota T, Takaki M, et al. Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients. Neuropsychiatr Dis Treat 2013;9:1565-71.
78. Kopala LC, Caudle C. Acute and longer-term effects of risperidone in a case of firstepisode catatonic schizophrenia. J Psychopharmacol 1998;12:314-7.
79. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord 1993;29:255-61.
80. Tan QR, Wang W, Wang HH, et al. Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol 2006;29:154-6.